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ABSTRACT
IMGT/3Dstructure-DB is the three-dimensional (3D)
structure database of IMGT, the international
ImMunoGenetics information system that is
acknowledged as the global reference in
immunogenetics and immunoinformatics. IMGT/
3Dstructure-DB contains 3D structures of
immunoglobulins (IG) or antibodies, T cell receptors
(TR), major histocompatibility complex (MHC)
proteins, antigen receptor/antigen complexes (IG/
Ag, TR/peptide/MHC) of vertebrates; 3D structures
of related proteins of the immune system (RPI) of
vertebrates and invertebrates, belonging to the
immunoglobulin and MHC superfamilies (IgSF and
MhcSF, respectively) and found in complexes
with IG, TR or MHC. IMGT/3Dstructure-DB data
are annotated according to the IMGT criteria,
using IMGT/DomainGapAlign, and based on the
IMGT-ONTOLOGY concepts and axioms. IMGT/
3Dstructure-DB provides IMGT gene and allele
identification (CLASSIFICATION), region and
domain delimitations (DESCRIPTION), amino acid
positions according to the IMGT unique numbering
(NUMEROTATION) that are used in IMGT/
3Dstructure-DB cards, results of contact analysis
and renumbered flat files. In its Web version, the
IMGT/DomainGapAlign tool analyses amino acid
sequences, per domain. Coupled to the IMGT/
Collier-de-Perles tool, it provides an invaluable
help for antibody engineering and humanization
design based on complementarity determining
region (CDR) grafting as it precisely defines the
standardized framework regions (FR-IMGT) and
CDR-IMGT. IMGT/3Dstructure-DB and IMGT/
DomainGapAlign are freely available at http://www
.imgt.org.
INTRODUCTION
IMGT/3Dstructure-DB (1) is the three-dimensional
(3D) structure database of IMGT, the international
ImMunoGenetics information system (http://www.imgt.
org) (2) that is acknowledged as the global reference in
immunogenetics and immunoinformatics (3). IMGT/
3Dstructure-DB contains 3D structures of (i) antigen
receptors that comprise immunoglobulins (IG) or
antibodies and T cell receptors (TR), (ii) major
histocompatibility complex (MHC) proteins of class I
(MHC-I) and class II (MHC-II), (iii) peptide/MHC
(pMHC) complexes (pMHC-I, pMHC-II), (iv) antigen
receptor/antigen complexes (IG/Ag, TR/pMHC) and (v)
related proteins of the immune system (RPI) belonging
to the immunoglobulin and MHC superfamilies
(IgSF and MhcSF, respectively) and found in
complexes with IG, TR or MHC. Major breakthroughs
characterize IMGT and, therefore, IMGT/3Dstructure-
DB: a standardized identiﬁcation (IMGT keywords), a
standardized nomenclature (IMGT gene and allele
names), a standardized description (IMGT labels) and a
standardized numerotation (IMGT unique numbering).
These rules are described in the IMGT Scientiﬁc chart
and are derived from the concepts of identiﬁcation, classi-
ﬁcation, description and numerotation, themselves genera-
ted from the IDENTIFICATION, CLASSIFICATION,
DESCRIPTION and NUMEROTATION axioms of
the Formal IMGT-ONTOLOGY, the ﬁrst ontology in
immunogenetics and immunoinformatics (4,5).
The IMGT/3Dstructure-DB structural data are
extracted from the Protein Data Bank (PDB) (6,7) and
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concepts of classiﬁcation, using internal tools and
IMGT/DomainGapAlign. Thus, IMGT/3Dstructure-DB
provides the closest genes and alleles that are expressed
in the amino acid sequences of the 3D structures, by
aligning these sequences with the IMGT domain reference
directory. This directory contains, for the antigen
receptors, amino acid sequences of the domains encoded
by the constant (C) genes and the translation of the
germline variable (V) and joining (J) genes. The identiﬁed
genes are classiﬁed based on the IMGT nomenclature of
IG and TR genes and alleles (8,9) that was approved in
1999 by the Human Genome Organisation (HUGO)
Nomenclature Committee (HGNC) (10), entered in
IMGT/GENE-DB (11) and endorsed by the World
Health Organization (WHO)-International Union of
Immunological Societies (IUIS) Nomenclature
Committee (12,13). Entrez Gene (14) at the National
Center for Biotechnology Information (NCBI),
Vertebrate Genome Annotation (Vega) (15) at the
Wellcome Trust Sanger Institute and Ensembl at the
European Bioinformatics Institute (EBI) currently use
IMGT nomenclature.
IMGT/3Dstructure-DB provides the IMGT Colliers de
Perles (16,17) that are 2D graphical representations based
on the IMGT unique numbering, the key IMGT-
ONTOLOGY concept of numerotation. IMGT Colliers
de Perles are currently available for three domain types:
V type (that includes the V-DOMAIN of IG and TR, and
V-LIKE-DOMAIN of the IgSF other than IG and TR)
(18), C type (that includes the C-DOMAIN of IG and TR,
and C-LIKE-DOMAIN of the IgSF other than IG and
TR) (19) and G type (that includes the G-DOMAIN of
MHC, and G-LIKE-DOMAIN of the MhcSF other than
MHC) (20).
IMGT-ONTOLOGY concepts have been crucial in
bridging the gap between sequences and 3D structures in
IMGT/3Dstructure-DB (21,22). Since 2008, amino acid
sequences of monoclonal antibodies (mAb, suﬃx -mab)
and of fusion proteins for immune applications (FPIA,
suﬃx -cept) from the World Health Organization/
International Nonproprietary Name (WHO/INN) have
been entered in IMGT. Being able to analyse sequences
and 3D structures with the same concepts of classiﬁcation
(nomenclature), description (labels) and numerotation
(IMGT unique numbering) facilitates comparative
studies of antigen receptors and FPIA, and of their con-
stitutive chains, even if 3D structures are not yet available.
Results from IMGT/DomainGapAlign and the associated
IMGT/Collier-de-Perles tool are widely used by
researchers, particularly for antibody engineering and
humanization design.
IMGT/3DStructure-DB DATABASE
Besides an increase in the number of IMGT/3Dstructure-
DB coordinate ﬁles (634 in 2004, 1649 in 2009), the
database itself was enhanced with (i) new data types
(IgSF other than IG and TR, MhcSF other than MHC),
(ii) novel functionalities that include chain sequences in
IMGT format, contact analysis of paratope/epitope,
‘IMGT pMHC contact sites’ (23,34) and ‘IMGT number-
ing comparison’ and (iii) improvement of the IMGT/
DomainGapAlign tool that allows the identiﬁcation
of the closest gene(s) and allele(s) expressed in
IMGT/3Dstructure-DB protein sequences and IG and
TR variable domains, by comparison with the IMGT
domain directory, and the display of amino acid
diﬀerences.
IMGT/3Dstructure-DB is queried through a user-
friendly interface and diﬀerent displays for the results
can be chosen from the database home page, as previously
described (1). Each entry in the database is detailed in an
IMGT/3Dstructure-DB card. Eight tabs are available at
the top of each card: ‘Chain details’, ‘Contact analysis’,
‘Paratope and epitope’, ‘3D visualization Jmol or
QuickPDB’, ‘Renumbered IMGT ﬁle’, ‘IMGT numbering
comparison’, ‘References and links’ and ‘Printable card’.
First, we will describe ‘Chain details’, and then a selection
of three features related to ‘Contact analysis’ (IMGT
Collier de Perles on two layers with hydrogen bonds,
IMGT pMHC contact sites, IMGT/3Dstructure-DB
Domain pair contacts) and the IMGT/DomainGapAlign
results in its Web version (Figure 1).
Statistics
In September 2009, the IMGT/3Dstructure-DB database
manages 1649 coordinate ﬁles that correspond to 1773
receptors (Table 1).
‘Other species’ refers to receptors from species other
than Homo sapiens (human) and Mus musculus (mouse),
and also to engineered proteins (humanized, chimeric or
synthetic). Thus, ‘Other species’ refers, for IG, to Camelus
dromedarius (36), Lama glama (10), Rattus norvegicus (14),
Ginglymostoma cirratum (6), Orectolobus maculatus (5),
Cricetinae gen. sp. (1), Oryctolagus cuniculus (1), Cavia
porcellus (1), humanized (23), chimeric (29) and synthetic
(18); for TR, to R. rattus (1); for MHC, to R. norvegicus
(3); and for RPI, to R. norvegicus (9), Hyalophora cecropia
(1), Branchiostoma ﬂoridae (2) and chimeric (2). A total of
318 diﬀerent genes (corresponding to 415 alleles) were
identiﬁed in V-DOMAIN: 266 for IG (155 IGHV,
93IGKV and 18IGLV) and 52 for TR (29 TRAV, 18
TRBV, 3 TRDV and 2 TRGV). IMGT/3Dstructure-DB
contains 920 antigen receptor/antigen complexes that
comprise 588 IG/Ag (141 human, 393 mouse and
54 ‘other species’) and 38 TR/pMHC (22 human, 16
mouse). There are 294 pMHC complexes (192 human,
99 mouse and 3 other species) (Table 1).
IMGT/3Dstructure-DB ‘Chain details’
The ‘Chain details’ (Figure 1A) comprises information,
ﬁrst on the chain itself, and then on each domain,
starting from the N-terminal end.
IMGT chain annotation includes:
. Chain ID;
. Chain length;
. IMGT chain description, with IMGT labels indicating
the constitutive domains and their delimitations [for
D302 Nucleic AcidsResearch, 2010, Vol.38,Database issueFigure 1. (A) IMGT/3Dstructure-DB ‘Chain details’. (B) IMGT Collier de Perles on two layers with hydrogen bonds. (C) IMGT pMHC contact
sites of human HLA-A*0201 MHC-I and a 9-amino acid peptide (1bd2). (D) IMGT/3Dstructure-DB Domain pair contacts between a V-BETA
domain and a ligand (1oga). (E) IMGT/DomainGapAlign Web results of alemtuzumab.
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. Chain sequence, with delimited regions (for example,
V-REGION, N-AND-REGION and J-REGION for
a V-BETA domain) and links to Sequence in FASTA
format and Sequence in IMGT format.
IMGT domain annotation includes:
. IMGT domain description;
. IMGT gene and allele name, with percentage of
identity and species, and a link to Alignment details
(V and J genes and alleles are given, in the case of a
V domain, as in Figure 1A);
. 2D representation, with links to IMGT Collier de
Perles (on one layer) and, for V and C type
domains, to IMGT Collier de Perles on two layers;
. Contact analysis, with a link to Domain contacts
(overview);
. CDR-IMGT lengths: lengths of the three CDR,
CDR1-IMGT, CDR2-IMGT and CDR3-IMGT,
shown between brackets and separated by dots, for
example [5.6.11], this information being determined
by IMGT/DomainGapAlign;
. Sheet composition: strands of each layer being
indicated between brackets, for example [A0BDE]
[A00CC0C00FG], this information being deduced from
the PDB ﬁle; and
. Domain amino acid sequence with gaps according
to the IMGT numbering and region delimitations
(for example, CDR1, CDR2, CDR3 for a
V-DOMAIN, as in Figure 1A) and a link to IMGT/
DomainGapAlign results.
IMGT Collier de Perles on two layers with
hydrogen bonds
IMGT Colliers de Perles on two layers, available for the
V and C type domains (18,19), are displayed with
hydrogen bonds (green lines in Figure 1B), this informa-
tion being determined from structural data extracted from
the PDB ﬁles. The V type domain is made of nine
antiparallel beta strands (A, B, C, C0,C 00, D, E, F and
G) linked by beta turns (AB, CC0,C 00D, DE and EF) or
loops (BC, C0C00 and FG), forming a sandwich of
two sheets (18). The sheets are closely packed against
each other through hydrophobic interactions giving a
hydrophobic core and joined together by a disulﬁde
bridge between the B-STRAND in the ﬁrst sheet and
the F-STRAND in the second sheet. In the IMGT
unique numbering, the conserved amino acids always
have the same position, for instance cysteine 23 (1st-
CYS), tryptophan 41 (CONSERVED-TRP), conserved
hydrophobic amino acid 89 and cysteine 104 (2nd-CYS)
(18). The C type domain has similar topology and 3D
structure than the V type domain, but it diﬀers by the
number of strands: it is made of seven beta strands
linked by beta turns or loops, and arranged so that
four strands form one sheet and three strands form a
second sheet (19). In September 2009, there are about
22000IMGT Colliers de Perles on two layers with
hydrogen bonds that correspond to 7300V and C
domains (Table 2).
Table 2. Number of IMGT/3Dstructure-DB data for IMGT Collier de Perles, Contact analysis and IMGT/DomainGapAlign
Number
a IG, TR, IgSF RPI
b MHC, MhcSF RPI
c
IMGT Collier de Perles
On one layer 9000 V, C G, C
On two layers with hydrogen bonds 22000 V, C nr
Contact analysis
IMGT pMHC contact sites 15000 nr Peptide – G
IMGT/3Dstructure-DB Domain pair contacts 45000 (V or C) – (V or C) (G or C) – (G or C)
(V or C) – (Ligand) (G or C) – (Ligand)
IMGT Residue@Position cards 1500000 V, C G, C
IMGT/DomainGapAlign
IMGT/DomainGapAlign results 9000 V, C G, C
aNumbers (September 2009) have been rounded oﬀ.
bIgSF RPI: IgSF proteins other than IG and TR.
cMhcSF RPI: MhcSF proteins other than MHC. MHC and MhcSF RPI also belong to IgSF RPI, by their C-like domain, if present.
V, V type; C, C type; G, G type; nr, not relevant.
Table 1. Number of receptors and complexes in IMGT/
3Dstructure-DB
Number per species
Homo sapiens Mus musculus Other species Total
Receptor type
IG 293 655 144 1092
TR 48 40 1 89
MHC 251 133 3 387
RPI 168 23 14 205




IG/Ag 141 393 54 588
TR/pMHC
TR/pMHC-I 17 10 0 27
TR/pMHC-II 5 6 0 11
peptide/MHC
pMHC-I 155 90 3 248
pMHC-II 37 9 0 46
Total 355 508 57 920
aComplexes involving RPI are not shown.
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‘IMGT pMHC contact sites’ graphically represent, in the
IMGT Colliers de Perles for G-DOMAIN (20), the MHC
amino acid positions that contact the peptide side chains
in pMHC complexes (Figure 1C), and thus allow compar-
ison of pMHC interactions (23,24). Eleven ‘IMGT pMHC
contact sites’ were deﬁned (C1–C11). They take into
account the length of the peptides and are considered
independently of the MHC class and sequence polymor-
phisms. All direct contacts (deﬁned with a cutoﬀ equal to
the sum of the atom van der Waals radii and of the
diameter of a water molecule) and water-mediated
hydrogen bonds are taken into account for the determina-
tion of the peptide/MHC interface. Amino acid positions
involved in the binding interface are ﬁltered and then clas-
siﬁed in the IMGT pMHC contact sites that combine
contact analysis (as detailed in next paragraph) with an
interaction scoring function. The score assigned to each
contact is a constant value, independent on the distance
between atoms [40 for direct hydrogen bond, 20 for water-
mediated hydrogen bond, 20 for polar interaction and 1
for nonpolar interaction (23)], which roughly complies
with the true mean energy ratio (25). The IMGT pMHC
contact sites allow to compare, for the ﬁrst time in a
database, the pMHC contacts whatever the MHC class
(I or II), whatever the G domain (G-ALPHA1,
G-ALPHA2, G-ALPHA or G-BETA) and whatever the
peptide length. This structural information is an impor-
tant asset in peptide vaccine design, particularly for
peptide binding to MHC-II as it allows to clearly
identify and to visualize amino acids in the groove.
IMGT/3Dstructure-DB Domain pair contacts
‘IMGT/3Dstructure-DB Domain pair contacts’
(Figure 1D) measure contacts between structural units
(domains or ligand). Contacts are obtained in IMGT/
3Dstructure-DB by a local program written in C in
which atoms are considered to be in contact when no
water molecule can take place between them. The cutoﬀ
using the diameter of a water molecule allows to identify
the van der Waals interactions. For the identiﬁcation of
hydrogen bonds, more stringent criteria are considered:
the distance between the donor and acceptor atoms must
be below or equal to 3.2 A ˚ ; the angle C–A–D, deﬁned by
the carbon connected to the acceptor atom (C), the
acceptor atom (A) and the donor atom (D), must be
above 90 ; the angle D–H–A, deﬁned by the donor atom
(D), the hydrogen atom given by the donor atom (H) and
the acceptor atom (A), must be above 140 . Two cases
arise: (i) if the hydrogen coordinates can be directly
computed (hydrogen linked to the backbone nitrogen, to
the nitrogen of the tryptophan side chain, etc.), the angle
is directly measured; (ii) in the case of the donor being
linked to a single heavy atom, the position of the
hydrogen cannot be directly computed (because of the
free rotation around the axis deﬁned by the donor and
this heavy atom). In that case the hydrogen atom is
supposed to be coplanar with the carbon linked to the
donor atom, the donor (D) and the acceptor (A). This
allows us to compute the D–H–A angle by a simple
geometric equation. The coplanar assumption is accept-
able given the free rotation mentioned above. The
angles’ and distances’ values used for the computation
are derived from (25). The atom contact types are
identiﬁed as ‘noncovalent’, ‘polar’, ‘hydrogen bond’,
‘nonpolar’, ‘covalent’ or ‘disulﬁde’ and the atom con-
tact categories as ‘(BB) Backbone/backbone’, ‘(SS) Side
chain/side chain’, ‘(BS) Backbone/side chain’ and ‘(SB)
Side chain/backbone’. As an example, Figure 1D shows
the ‘IMGT/3Dstructure-DB Domain pair contacts’
between a V-BETA domain and its ligand (a peptide
bound to a MHC). Twelve domain pair contacts,
involving 11 diﬀerent residues, 6 from V-BETA and 5
from the peptide, are listed with information on the
atom contact types. Positions that belong to the CDR-
IMGT are highlighted as they contribute to the speciﬁcity
of the antigen receptors: red (CDR1-IMGT), orange
(CDR2-IMGT) and purple (CDR3-IMGT), according to
the IMGT color menu (same colors as in Figure 1B).
In September 2009, IMGT/3Dstructure-DB contains
 45000 domain pair contacts (Table 2).
The atom contact types and categories for each amino
acid are provided in ‘IMGT Residue@Position cards’. A
Residue@Position is deﬁned by the position numbering
(for example 23), according to the IMGT unique number-
ing, the residue name in the three-letter abbreviation
and in the one-letter abbreviation for amino acids
[e.g. CYS (C)], the IMGT domain description (e.g.
V-BETA) and the IMGT chain ID (e.g. 1oga_E).
‘IMGT Residue@Position card’ can be obtained by
clicking on ‘R@P’ in ‘IMGT/3Dstructure-DB Domain
pair contacts’ (Figure 1D), or on any residue in the
‘IMGT Collier de Perles on one layer’ or in the amino
acid sequence. In September 2009, IMGT/3Dstructure-
DB contains about 1500000IMGT Residue@Position
contacts (Table 2).
IMGT/DomainGapAlign
IMGT/DomainGapAlign, used internally for the analysis
of amino acid sequences in IMGT/3Dstructure-DB, is also
available on the Web. The tool aligns the user amino acid
sequences with the IMGT domain reference directory,
identiﬁes the closest V, C and G domains, creates gaps
according to the IMGT unique numbering and highlights
diﬀerences with the closest reference(s). For an antibody V
domain sequence, IMGT/DomainGapAlign identiﬁes
the closest germline V-REGION and J-REGION, and
provides a delimitation of the strands, framework
regions (FR-IMGT) and CDR-IMGT (Figure 1E). The
IMGT gene and allele name of the closest sequence(s)
from the IMGT domain reference directory is provided
with a percentage of identity and a Smith–Waterman
score. Regions and domains are highlighted using the
IMGT Color menu. Several sequences can be analysed
simultaneously and users can choose how many
alignments to display for each sequence. The IMGT
Colliers de Perles are generated from the sequences
provided by IMGT/DomainGapAlign tool.
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The IMGT standardization has allowed to build a
unique frame for the comparison of the IG, TR and
MHC structural data and interactions with their ligands.
That standardization has been extended to the IgSF and
MhcSF proteins that involve V, C and/or G type domains
(26–29) and used, as an example, to develop a binding
prediction method for MhcSF G type domain and
beta2-microglobulin (30). IG/Ag and TR/pMHC
complexes can be queried from the IMGT/3Dstructure-
DB home page. IMGT/3Dstructure-DB data are particu-
larly useful in antibody engineering and humanization
design. Indeed they allow to precisely deﬁne and to
easily compare amino acid sequences of the FR-IMGT
and CDR-IMGT, between the nonhuman (mouse,
rat, etc.) and the closest human V domains. A recent
analysis performed on humanized antibodies used in
oncology underlines the importance of a correct
delimitation of the CDR to be grafted (31).
IMGT3Dstructure-DB facilitates the identiﬁcation of
potential immunogenic residues at given positions in
chimeric or humanized antibodies, including those of the
constant domains (32,33). Moreover, the low potential
immunogenicity of nonhuman primate antibodies and
their potential use as therapeutics in humans has been
shown by this approach (34,35). This is particularly
important for nonhuman primate antibodies neutralizing
Bacillus anthracis and the anthrax lethal toxin or the
ricin toxin that could be used as therapeutics in ricin
intoxication and against bioweapons (36,37). These ther-
apeutic applications emphasize the importance of the
IMGT/3Dstructure-DB standardized approach that
bridges the gap between sequences and 3D structures
whatever the species.
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